Article Correctness Is Author's Responsibility: FDA Issues Statement Addressing Safety Concerns Associated With Nuplazid

The article below may contain offensive and/or incorrect content.

Based on the data, the FDA has concluded that the drug's benefit continues to outweigh its risks for patients with hallucinations and delusions associated with Parkinson's disease psychosis.